MBRX Stock Price History and Quote Analysis: Insights for Investors
Moleculin Biotech, Inc.
Stock Price Today
Moleculin Biotech, Inc. (MBRX) stock surged +6.36%, trading at $2.51 on NASDAQ, up from the previous close of $2.36. The stock opened at $2.40, fluctuating between $2.40 and $2.58 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of drug candidates for the treatment of highly resistant tumors and viruses. Its lead drug candidate is Annamycin that is in Phase 1/2 studies for the treatment of relapsed or refractory acute myeloid leukemia (AML) and cancers metastasized to the lungs. The company's flagship immune/transcription modulator is WP1066, which is in Phase I clinical trial for the treatment of brain tumors and pediatric brain tumors, as well as pancreatic cancer and other malignancies. It also develops WP1220, an analog of WP1066 for the topical treatment of cutaneous T-cell lymphoma; and WP1122 to treat glioblastoma multiforme and COVID-19. The company has partnership and collaboration agreements with MD Anderson; Animal Life Sciences, LLC; and WPD Pharmaceuticals Sp z.o.o. Moleculin Biotech, Inc. was incorporated in 2015 and is headquartered in Houston, Texas.
Company Information
| Employees | 18 |
| Beta | 1.849 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Moleculin Biotech, Inc. (NASDAQ: MBRX) stock price is $2.51 in the last trading session. During the trading session, MBRX stock reached the peak price of $2.58 while $2.40 was the lowest point it dropped to. The percentage change in MBRX stock occurred in the recent session was 6.36% while the dollar amount for the price change in MBRX stock was $0.15.
The NASDAQ listed MBRX is part of Biotechnology industry that operates in the broader Healthcare sector. Moleculin Biotech, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Walter V. Klemp
Founder, Chairman, Pres & Chief Executive Officer
Mr. Jonathan P. Foster CPA
Executive Vice President & Chief Financial Officer
Ms. Jacqueline Northcut
Consultant
Mr. Louis Ploth Jr.
Independent Advisor
Dr. Robert C. Shepard FACP, M.D., F.A.C.P.
Chief Medical Officer of Annamycin
Dr. Wolfram C. M. Dempke M.B.A., M.D., Ph.D.
European Chief Medical Officer
Dr. John Paul Waymack M.D., Sc.D.
Senior Chief Medical Officer
MBRX's closing price is 492.97% higher than its 52-week low of $0.40 where as its distance from 52-week high of $6.24 is -62.18%.
Number of MBRX employees currently stands at 18.
Official Website of MBRX is: https://www.moleculin.com
MBRX could be contacted at phone 713 300 5160 and can also be accessed through its website. MBRX operates from 5300 Memorial Drive, Houston, TX 77007, United States.
MBRX stock volume for the day was 27.42K shares. The average number of MBRX shares traded daily for last 3 months was 39.72K.
The market value of MBRX currently stands at $7.14M with its latest stock price at $2.51 and 2.84M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com